Icotrokinra is efficacious and safe for treating moderate to severe plaque psoriasis among adolescents and adults when compared with placebo.

Ahmedabad: A consumer commission has ordered an insurance company to reimburse Rs 4.25 lakh with interest to a policyholder ...

Women with psoriasis show shorter drug survival for biologics, including IL-17/23 inhibitors, due to lower satisfaction and ...

Psoriatic arthritis is a combination of psoriasis and arthritis symptoms. You may have skin and nail changes, joint pain and ...

If you’re experiencing a flaking, itching scalp, you may do a quick self-diagnosis of dandruff. But that flaking and itching ...

A growing momentum for earlier treatment of psoriasis has the potential to improve outcomes with oral therapies and biologics ...

Two phase 2 trials with different selective TYK2 inhibitors produce high rates of efficacy in moderate to severe plaque ...

Less than a quarter of patients diagnosed with mild psoriasis had a body surface area of less than 3% at the time of diagnosis.

Posters presented at the 2025 American Academy of Dermatology Annual Meeting found tildrakizumab outcomes to have a mean drug ...

Struggling with dark spots? Learn what causes hyperpigmentation, how to prevent it, and the best treatments—from skincare ...

LEO Pharma and Reig Jofre have entered into a partnership aimed at improving access to LEO’s psoriasis treatment in Europe.

You may be able to manage mild psoriasis on your feet with home remedies such as moisturizers and over-the-counter treatments like hydrocortisone 1% cream. However, more severe psoriasis may ...